
In June, I presented a bulletproof, or hedged, portfolio around a position in Johnson & Johnson.
This portfolio was designed to last six months. Here, I show how it has performed at its halfway point.
So far, this portfolio is down 2.45%, underperforming SPY, but outperforming Johnson & Johnson and its other unhedged components.
Looking for a helping hand in the market? Members of Bulletproof Investing get exclusive ideas and guidance to navigate any climate.
READ FULL ARTICLE HERE

